Please find enclosed herewith the Outcome of Board Meeting held on May 18, 2026
GPTHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
GPT Healthcare Limited reported FY26 total income of ₹47,849.82 lakhs (up 15.1% from ₹41,558.57 lakhs in FY25), with Q4 revenue at ₹12,637.18 lakhs. However, profit after tax declined 14.4% to ₹4,272.05 lakhs from ₹4,992.17 lakhs due to significantly higher finance costs (up 137% to ₹824.04 lakhs) and increased depreciation (up 42% to ₹2,708.83 lakhs). EPS for FY26 stood at ₹5.15 versus ₹6.08 in the prior year. The Board recommended a final dividend of ₹1.50 per share (15%), which combined with the already paid interim dividend of ₹1.00 per share totals ₹2.50 per share for FY26. Statutory auditors S R Batliboi & Co. LLP issued an unmodified (clean) opinion on the financial results.
While revenue grew 16% YoY, the decline in profitability and EPS may concern investors focused on bottom-line growth. The increased dividend payout (₹2.50 per share) signals management confidence but could face resistance given lower PAT. The clean audit opinion is positive. The stock may see mixed reaction as revenue growth is offset by margin compression.